Constantine Ginger 4
4 · SAVIENT PHARMACEUTICALS INC · Filed May 24, 2012
Insider Transaction Report
Form 4
Constantine Ginger
Director
Transactions
- Award
Common Stock, $.01 par value per share
2012-05-22$0.81/sh+49,382$39,999→ 65,015 total - Award
Option to Purchase Common Stock, $0.01 par value
2012-05-22$0.81/sh−69,728$56,480→ 69,728 totalExercise: $0.81From: 2012-08-22Exp: 2022-05-22→ Common Stock, $0.01 par value (69,728 underlying)
Footnotes (2)
- [F1]The right to receive these shares is pursuant to a restricted stock unit grant which shall vest 31 days from the first anniversary of the grant date.
- [F2]The stock options will vest equally every three months beginning on August 22, 2012, with the last tranche vesting on the earlier of May 22, 2013 or the Company's 2013 Annual Meeting of Stockholders.